Healthcare Nanotechnology Market Size and Forecast 2024-2033|Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Celgene Corporation, Merck & Company Inc

Open capsule or pill with molecular structure. Nanotechnology concept

Overview and Scope

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.

Sizing and Forecast

The healthcare nanotechnology market size has grown rapidly in recent years. It will grow from $308.03 billion in 2023 to $351.82 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, nanostructured biomaterials.

The healthcare nanotechnology market size is expected to see rapid growth in the next few years. It will grow to $613.9 billion in 2028 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, global health emergency preparedness.. Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and educationtherapeutic applications..

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Segmentation & Regional Insights

The healthcare nanotechnology market covered in this report is segmented –

1) By Disease: Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases

2) By Type: Organic, Inorganic, Carbon-Based

3) By Application: Drug Delivery, Biomaterials, Active Implants, Tissue Regeneration

North America was the largest region in the healthcare nanotechnology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5762&type=smp

Major Driver Impacting Market Growth

Increasing cancer disease cases are expected to propel the growth of the healthcare nanotechnology market. Nanotechnology is a promising mode of cancer treatment. This improving field of medical research can be used to discover better personalized treatments for many diseases, including cancer. Globally, the prevalence of cancer is increasing. For instance, in January 2021, according to the National Library of Medicine the United States is projected to have 1,898,160 new cancer cases and 608,570 cancer deaths in 2021 . Therefore, the increasing number of cancer disease cases is driving the healthcare nanotechnology market growth.

Key Industry Players

Major companies operating in the healthcare nanotechnology market report are Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Celgene Corporation, Merck & Company Inc., Union Chimique Belge S. A, Teva Pharmaceutical Industries Ltd., Sanofi SA, Taiwan Liposome Company Ltd., GE Healthcare Technologies Inc., Mallinckrodt plc, Leadiant Biosciences, Luminex Corporation, Bristol-Myers Squibb Company, CytImmune Sciences Inc., Nanobiotix, Starpharma Holdings Limited, Copernicus Therapeutics Inc., NanoCarrier Co. Ltd, Ensysce Biosciences Inc., Ocuphire Pharma Inc., LiPlasome Pharma ApS, Nami Therapeutics Corp., Nanospectra Biosciences Inc., Genetic Immunity Inc., Spago Nanomedical AB, Nanobiosym Inc., Nanopoint Inc., Nanosphere Health Sciences Inc., Nanoviricides Inc., Nanotherapeutics Inc., Nanosyn Inc., Nanoscale Corporation, Nanosys Inc., Nanocarrier Co. Ltd., Nanocor Therapeutics Inc., Nanocyl SA, Nanogen Pvt. Ltd.

The healthcare nanotechnology market report table of contents includes:

1. Executive Summary

2. Healthcare Nanotechnology Market Characteristics

3. Healthcare Nanotechnology Market Trends And Strategies

4. Healthcare Nanotechnology Market – Macro Economic Scenario

5. Global Healthcare Nanotechnology Market Size and Growth

26. South America Healthcare Nanotechnology Market

27. Brazil Healthcare Nanotechnology Market

28. Middle East Healthcare Nanotechnology Market

29. Africa Healthcare Nanotechnology Market

30. Healthcare Nanotechnology Market Competitive Landscape And Company Profiles

Top Major Players: